PolyPid (PYPD, Financial) received an update from analyst Roy Buchanan at JMP Securities on June 17, 2025. The analyst has maintained the "Market Outperform" rating for PolyPid, indicating a positive outlook for the stock's performance relative to the broader market.
However, in a notable adjustment, Buchanan has lowered the price target for PYPD from $16.00 to $14.00 USD. This new target represents a 12.5% decrease from the previous estimation. Despite the reduction in the price target, the maintained rating suggests continued confidence in the company's potential to outperform its peers.
Investors and stakeholders will be keenly observing how PolyPid (PYPD, Financial) navigates market conditions following this updated guidance from JMP Securities.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for PolyPid Ltd (PYPD, Financial) is $13.50 with a high estimate of $15.00 and a low estimate of $12.00. The average target implies an upside of 281.35% from the current price of $3.54. More detailed estimate data can be found on the PolyPid Ltd (PYPD) Forecast page.
Based on the consensus recommendation from 4 brokerage firms, PolyPid Ltd's (PYPD, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
